Aug 2026· Angewandte Chemie· Vol 65, pp.
e5508153
· 0 citations· 78 references
Medicine
TL;DR
This study proposes that aaRSs can recognize halogenated ncAAs through halogen bonding (XB), and confirms that ncAA recognition by aaRSs occurs through XB, and shows that XB can serve as a driving force for expanding the genetic code with ncAAs.
Abstract
Aminoacyl-tRNA synthetases (aaRSs) catalyze the attachment of amino acids (AAs) to their cognate tRNAs during protein synthesis. As aaRSs possess highly selective amino acid-binding sites, a distinct enzyme is generally required for each amino acid in the genetic code. Recently, genetic code expansion (GCE) has emerged as a powerful strategy for incorporating non-canonical amino acids (ncAAs) during ribosomal translation, enabling the production of proteins with novel structures and functions. In this study, we propose that aaRSs can recognize halogenated ncAAs through halogen bonding (XB), and that the stronger XB-forming ability of iodine, compared with chlorine or bromine, enables the selective incorporation of 3,5-diiodo-l-tyrosine into proteins. We demonstrate the successful generation of aaRSs that specifically recognize 3,5-diiodo-l-tyrosine during translation, even in the presence of closely related amino acids such as 3,5-dichloro-, 3,5-dibromo-, and 3,5-dimethyl-l-tyrosine. These results confirm that ncAA recognition by aaRSs occurs through XB. Overall, this study not only shows that XB can serve as a driving force for expanding the genetic code with ncAAs, but also demonstrates that aaRSs can be engineered to discriminate among structurally similar ncAAs that differ by only a single atom.
The potential of BpyAla-mediated nucleic acid cleavage is discussed, with emphasis on the development of next-generation BpyAla analogues, the exploration of alternative metal cofactors, cooperative and multi-residue design strategies, and the expansion of compatible protein scaffolds and nucleic acid substrates.
Eryn Lundrigan, Matthew T. O'Neill, J. P. Pezacki· Frontiers in Chemical Biolog...· 0 citations
Over the past two decades, engineering efforts have yielded aminoacyl-tRNA synthetases (aaRSs) capable of charging diverse noncanonical amino acids (ncAAs). Here, we report an unexpected and exploitable activity of these engineered aaRSs: In the absence of their cognate tRNA, aaRSs can release the ncAA-AMP intermediate...
T. Yared, Elise D. Ficaretta, Lena A. Voss et al.· ACS Chemical Biology· 0 citations
Strategies for site-specific incorporation of noncanonical amino acids have advanced substantially, enabling access to proteins containing numerous analogues. That noted, many interesting analogues are not α-L-amino acids, and the incorporation of such compounds often requires the development and use of engineered ribo...
Shadow B Harmon, Omar M. Khdour, L. Dedkova et al.· ACS Chemical Biology· 0 citations
Recent advances in fully autonomous ncAA biosynthesis for GCE technology across microbial, zebrafish, and mammalian systems are summarized and emerging applications of these biosynthetic strategies in biological research and therapeutic development are highlighted.
Dan Wu, Mengxi Zhang, Yu Hu et al.· Angewandte Chemie· 0 citations
In eubacteria, decoding of isoleucine codon AUA requires a specialized tRNA (tRNAIle2) modified with lysidine (k2C) at the anticodon wobble position (C34), which switches decoding specificity from methionine (AUG) to isoleucine (AUA). Recently, aminovaleramide cytidine (ava2C) was discovered at the same tRNA position i...
Jing-Jing Sun, Jun-Zhou Wu, Yi-Feng Yuan et al.· Nature Chemical Biology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.